OnKure Therapeutics Inc. Class A (OKUR)
NASDAQ: OKURHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
OKUR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $95.17M
- EPS (TTM)
- -$2.90
- Dividend yield
- None
- 52-week range
- 2.23 – 5.38
- Day range
- 2.30 – 2.46
- Volume / Avg
- 260.72K / 210.66K
- Beta
- —
- Shares outstanding
- 40.50M
- Next earnings
- Nov 5, 2026
52-week range
OKUR stock today
Shares of OnKure Therapeutics (OKUR) finished lower on Oct 7 at $2.35, a drop of 4.47% or $0.11 per share, versus the S&P 500's 0.22% decline. Shares are 56.3% below their 52-week high of $5.38, set on May 1, 2026 and 5.4% above the 52-week low of $2.23, near the bottom of the past year's range. OKUR is down 19.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 21.4%.
OnKure Therapeutics has posted a net loss over the last twelve months (EPS of -$2.90), so its P/E ratio is not meaningful. OnKure Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About OnKure Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Boulder, CO
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.35
OnKure Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BMEABiomea Fusion Inc. | 1.32 | +5.60% | $95.44M | vs OKUR |
| MISTMilestone Pharmaceuticals Inc. | 0.7572 | -0.92% | $94.27M | vs OKUR |
| CTORCitius Oncology Inc. | 0.851 | +0.12% | $90.00M | vs OKUR |
| RLYBRallybio Corporation | 16.93 | -0.88% | $89.94M | vs OKUR |
| EQEquillium Inc. | 1.39 | -2.11% | $88.14M | vs OKUR |
| ANIXAnixa Biosciences Inc. | 2.95 | -2.32% | $102.55M | vs OKUR |
| CPIXCumberland Pharmaceuticals Inc. | 6.89 | -3.50% | $103.23M | vs OKUR |
| IMUXImmunic Inc. | 7.63 | -2.43% | $104.11M | vs OKUR |
Indexes, lists and sector
OnKure Therapeutics stock FAQ
What is OnKure Therapeutics's stock price today?
OKUR last traded at $2.35 as of Oct 7, 4:00 PM EDT, down 4.47% on the day. Prices are delayed at least 15 minutes.
Does OnKure Therapeutics pay a dividend?
No. OnKure Therapeutics does not currently pay a regular cash dividend.
When is OnKure Therapeutics's next earnings date?
OnKure Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.35.
Has OKUR ever split its stock?
Yes. The most recent OKUR stock split was a 1-for-10 split on Oct 7, 2024.
What is the OKUR 52-week high?
The 52-week high for OKUR is $5.38 and the 52-week low is $2.23. The stock is currently 56.3% below its high.